ISPOR 2026 reflections: AI, access, and the evolving role of RWE in oncology
Informing global evidence strategies with real-world data across multiple geographies
Behind the Research: An Exploration of Real-World Data's Ability to Support Adverse Event Surveillance at ISPOR Europe
From Obligation to Opportunity: Accelerating Safety Evidence Using Digital and Pragmatic Solutions
How to incorporate pragmatic design elements into your clinical studies
Reducing burden and filling evidence generation gaps with Flatiron Trials™
.png)
The future of identifying fit-for-purpose real-world evidence for regulatory submissions: A breakdown of the Reagan-Udall Foundation for the FDA QCARD Initiative
